FDA Inspection 893648 — Vitalant

Vitalant — FEI 2971457

The FDA completed an inspection of Vitalant on August 19, 2014 in Las Vegas, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Las Vegas, NV (United States)

Citations

IDCFRDescription
8821 CFR 606.100(b)(9)Written methods for investigating adverse reactions